Mexico Infectious Disease Molecular Diagnostics Market Size & Outlook

The infectious disease molecular diagnostics market in Mexico is expected to reach a projected revenue of US$ 214.6 million by 2028. A compound annual growth rate of 2.7% is expected of Mexico infectious disease molecular diagnostics market from 2021 to 2028.

Revenue, 2020 (US$M)
$173.4
Forecast, 2028 (US$M)
$214.6
CAGR, 2021 - 2028
2.7%
Report Coverage
Mexico

Mexico infectious disease molecular diagnostics market, 2018-2028 (US$M)

Mexico

Mexico infectious disease molecular diagnostics market highlights

  • The Mexico infectious disease molecular diagnostics market generated a revenue of USD 173.4 million in 2020 and is expected to reach USD 214.6 million by 2028.
  • The Mexico market is expected to grow at a CAGR of 2.7% from 2021 to 2028.
  • In terms of segment, reagents was the largest revenue generating product in 2020.
  • Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Infectious disease molecular diagnostics market data book summary

Market revenue in 2020USD 173.4 million
Market revenue in 2028USD 214.6 million
Growth rate2.7% (CAGR from 2020 to 2028)
Largest segmentReagents
Fastest growing segmentReagents
Historical data2018 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Reagents
Key market players worldwideAbbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp


Other key industry trends

  • In terms of revenue, Mexico accounted for 0.5% of the global infectious disease molecular diagnostics market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Latin America, Brazil infectious disease molecular diagnostics market is projected to lead the regional market in terms of revenue in 2028.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 214.6 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Infectious Disease Molecular Diagnostics Market Companies

Name Profile # Employees HQ Website

Mexico infectious disease molecular diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.


Reagents was the largest segment with a revenue share of 67.07% in 2020. Horizon Databook has segmented the Mexico infectious disease molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2028.


Mexico is a prominent market for infectious diseases molecular diagnostics in Latin America. Due to the large population, controlling the incidence of infectious diseases is a major challenge in Mexico. Healthcare institutions have undertaken initiatives to spread awareness about early diagnosis of infectious diseases through healthcare camps. 

Favorable government regulations pertaining to approval of molecular diagnostics are expected to boost market growth. In Mexico, COFEPRIS—division of the Mexican Ministry of Health—governs the approval process for IVDs and molecular diagnostics.

The organization announced these plans in early 2017. For instance, in July 2020, COFEPRIS approved DiaCarta’s QuantiVirus SARS-CoV-2 test for marketing in Mexico, which is a PCRbased test. The test has been evaluated and approved by the Ministry of Health through the Institute of Diagnostic and Epidemiological Reference (InDRE), in compliance with the guidelines established by WHO.

Reasons to subscribe to Mexico infectious disease molecular diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico infectious disease molecular diagnostics market databook

  • Our clientele includes a mix of infectious disease molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico infectious disease molecular diagnostics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico infectious disease molecular diagnostics market size, by product, 2018-2028 (US$M)

Mexico Infectious Disease Molecular Diagnostics Market Outlook Share, 2020 & 2028 (US$M)

Mexico infectious disease molecular diagnostics market size, by product, 2018-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more